Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Arrest | 5 | 2018 | 265 | 1.880 |
Why?
|
Anesthesiologists | 2 | 2018 | 29 | 1.250 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2018 | 190 | 1.000 |
Why?
|
Intraoperative Complications | 3 | 2015 | 185 | 0.960 |
Why?
|
Operating Rooms | 3 | 2018 | 126 | 0.880 |
Why?
|
Anesthesia | 4 | 2016 | 164 | 0.840 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 297 | 0.750 |
Why?
|
Intensive Care Units | 6 | 2020 | 373 | 0.610 |
Why?
|
Data Mining | 1 | 2016 | 42 | 0.570 |
Why?
|
Sample Size | 1 | 2016 | 130 | 0.570 |
Why?
|
Physician's Role | 1 | 2018 | 179 | 0.550 |
Why?
|
Databases, Factual | 2 | 2016 | 812 | 0.550 |
Why?
|
Disease Management | 1 | 2018 | 327 | 0.540 |
Why?
|
Biomedical Research | 1 | 2019 | 375 | 0.520 |
Why?
|
Clinical Alarms | 3 | 2019 | 16 | 0.490 |
Why?
|
Molecular Imaging | 1 | 2015 | 64 | 0.480 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2015 | 139 | 0.440 |
Why?
|
Limb Deformities, Congenital | 1 | 2012 | 21 | 0.440 |
Why?
|
Informed Consent | 1 | 2015 | 266 | 0.430 |
Why?
|
Advanced Cardiac Life Support | 1 | 2012 | 13 | 0.430 |
Why?
|
Mammography | 1 | 2015 | 461 | 0.410 |
Why?
|
General Practice | 1 | 2011 | 8 | 0.400 |
Why?
|
Correspondence as Topic | 1 | 2011 | 4 | 0.400 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 1169 | 0.400 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 392 | 0.390 |
Why?
|
Femoracetabular Impingement | 2 | 2020 | 11 | 0.360 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 351 | 0.350 |
Why?
|
Postoperative Complications | 3 | 2015 | 2207 | 0.330 |
Why?
|
Drosophila Proteins | 4 | 2022 | 488 | 0.330 |
Why?
|
Referral and Consultation | 1 | 2011 | 326 | 0.320 |
Why?
|
Safety Management | 2 | 2011 | 56 | 0.320 |
Why?
|
Mental Fatigue | 2 | 2018 | 9 | 0.320 |
Why?
|
Humans | 44 | 2020 | 86617 | 0.310 |
Why?
|
Organizational Culture | 1 | 2007 | 33 | 0.300 |
Why?
|
Hospital Units | 1 | 2007 | 30 | 0.300 |
Why?
|
Anesthesia, General | 3 | 2011 | 114 | 0.300 |
Why?
|
Nursing Staff, Hospital | 1 | 2007 | 42 | 0.300 |
Why?
|
Critical Illness | 6 | 2018 | 294 | 0.270 |
Why?
|
Drosophila melanogaster | 2 | 2022 | 599 | 0.260 |
Why?
|
Blood Glucose | 1 | 2009 | 873 | 0.250 |
Why?
|
Consciousness Monitors | 2 | 2015 | 4 | 0.240 |
Why?
|
Pulmonary Alveoli | 2 | 2015 | 71 | 0.230 |
Why?
|
Monitoring, Intraoperative | 2 | 2015 | 109 | 0.220 |
Why?
|
Wings, Animal | 2 | 2022 | 95 | 0.220 |
Why?
|
Larva | 3 | 2022 | 118 | 0.210 |
Why?
|
Emergency Medical Services | 2 | 2015 | 209 | 0.210 |
Why?
|
Water-Electrolyte Balance | 1 | 2001 | 66 | 0.200 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 93 | 0.200 |
Why?
|
Lactic Acid | 1 | 2001 | 90 | 0.200 |
Why?
|
Chlorides | 1 | 2001 | 103 | 0.200 |
Why?
|
Breast Neoplasms | 1 | 2015 | 2887 | 0.200 |
Why?
|
Awareness | 1 | 2001 | 93 | 0.190 |
Why?
|
Blood Gas Analysis | 1 | 2020 | 37 | 0.190 |
Why?
|
Body Patterning | 1 | 2022 | 209 | 0.180 |
Why?
|
Respiration, Artificial | 4 | 2010 | 334 | 0.180 |
Why?
|
Catheters | 1 | 2020 | 74 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 1373 | 0.170 |
Why?
|
Uncertainty | 1 | 2019 | 71 | 0.170 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 102 | 0.170 |
Why?
|
Osteoarthritis, Hip | 1 | 2018 | 23 | 0.170 |
Why?
|
Electroencephalography | 2 | 2011 | 709 | 0.160 |
Why?
|
Propofol | 4 | 2001 | 89 | 0.160 |
Why?
|
Perioperative Period | 1 | 2018 | 25 | 0.160 |
Why?
|
Oxygen | 2 | 2020 | 726 | 0.160 |
Why?
|
Resuscitation | 1 | 2018 | 100 | 0.160 |
Why?
|
Hemocytes | 1 | 2017 | 4 | 0.160 |
Why?
|
Inhibin-beta Subunits | 1 | 2017 | 4 | 0.160 |
Why?
|
Hematopoietic System | 1 | 2017 | 13 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2022 | 623 | 0.150 |
Why?
|
Sensory Receptor Cells | 1 | 2017 | 35 | 0.150 |
Why?
|
Critical Care | 2 | 2019 | 370 | 0.150 |
Why?
|
Machine Learning | 1 | 2019 | 232 | 0.150 |
Why?
|
Data Accuracy | 1 | 2016 | 31 | 0.140 |
Why?
|
Inventions | 1 | 2016 | 13 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 103 | 0.140 |
Why?
|
Hematopoiesis | 1 | 2017 | 163 | 0.140 |
Why?
|
Middle Aged | 12 | 2015 | 25017 | 0.140 |
Why?
|
Probability | 1 | 2016 | 355 | 0.140 |
Why?
|
Research Design | 1 | 2019 | 594 | 0.140 |
Why?
|
Biomarkers | 4 | 2018 | 1718 | 0.130 |
Why?
|
Hypotension | 1 | 2015 | 70 | 0.130 |
Why?
|
Lung Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
Aged, 80 and over | 2 | 2015 | 6501 | 0.120 |
Why?
|
Checklist | 1 | 2014 | 57 | 0.120 |
Why?
|
Airway Management | 1 | 2015 | 46 | 0.120 |
Why?
|
Heart Diseases | 1 | 2016 | 290 | 0.120 |
Why?
|
Risk Factors | 3 | 2015 | 5417 | 0.120 |
Why?
|
Radiation Dosage | 1 | 2015 | 227 | 0.120 |
Why?
|
Prospective Studies | 6 | 2015 | 4212 | 0.120 |
Why?
|
Midazolam | 3 | 2000 | 48 | 0.120 |
Why?
|
Female | 16 | 2018 | 44509 | 0.120 |
Why?
|
Aged | 8 | 2015 | 18402 | 0.120 |
Why?
|
Drosophila | 3 | 2008 | 498 | 0.120 |
Why?
|
Naltrexone | 3 | 2000 | 135 | 0.120 |
Why?
|
Narcotic Antagonists | 3 | 2000 | 154 | 0.110 |
Why?
|
Adult | 11 | 2018 | 25640 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 150 | 0.110 |
Why?
|
Models, Statistical | 1 | 2016 | 574 | 0.110 |
Why?
|
Perioperative Care | 1 | 2014 | 161 | 0.110 |
Why?
|
Anesthesiology | 1 | 2015 | 157 | 0.110 |
Why?
|
Hypnotics and Sedatives | 3 | 2000 | 125 | 0.110 |
Why?
|
Male | 18 | 2018 | 40958 | 0.110 |
Why?
|
Cystatin C | 2 | 2010 | 31 | 0.110 |
Why?
|
Esophagus | 1 | 2012 | 102 | 0.100 |
Why?
|
Intraoperative Awareness | 1 | 2011 | 2 | 0.100 |
Why?
|
Spine | 1 | 2012 | 102 | 0.100 |
Why?
|
Anal Canal | 1 | 2012 | 89 | 0.100 |
Why?
|
Accreditation | 1 | 2011 | 60 | 0.100 |
Why?
|
Trachea | 1 | 2012 | 293 | 0.100 |
Why?
|
Registries | 1 | 2015 | 702 | 0.100 |
Why?
|
Survival Analysis | 1 | 2015 | 1538 | 0.100 |
Why?
|
Hypocapnia | 1 | 2010 | 6 | 0.100 |
Why?
|
Fever of Unknown Origin | 1 | 2010 | 5 | 0.100 |
Why?
|
Anesthetics, Inhalation | 1 | 2011 | 95 | 0.100 |
Why?
|
Absorptiometry, Photon | 1 | 2011 | 99 | 0.100 |
Why?
|
Time Factors | 6 | 2012 | 5209 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2011 | 93 | 0.090 |
Why?
|
Cardiopulmonary Bypass | 3 | 2000 | 148 | 0.090 |
Why?
|
Electroconvulsive Therapy | 1 | 2010 | 24 | 0.090 |
Why?
|
Radiography | 1 | 2012 | 813 | 0.090 |
Why?
|
Age Factors | 1 | 2015 | 1849 | 0.090 |
Why?
|
Computer Simulation | 1 | 2014 | 1078 | 0.090 |
Why?
|
Osteoporosis | 1 | 2011 | 121 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 2010 | 144 | 0.090 |
Why?
|
False Positive Reactions | 2 | 2020 | 216 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 47 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 92 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2010 | 137 | 0.090 |
Why?
|
Arthroscopy | 2 | 2020 | 94 | 0.090 |
Why?
|
Infant, Newborn | 1 | 2015 | 2378 | 0.080 |
Why?
|
Clinical Competence | 1 | 2014 | 751 | 0.080 |
Why?
|
Kidney Function Tests | 1 | 2009 | 123 | 0.080 |
Why?
|
Depressive Disorder, Major | 1 | 2010 | 158 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2019 | 268 | 0.080 |
Why?
|
Signal Transduction | 3 | 2008 | 3241 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2020 | 160 | 0.080 |
Why?
|
Algorithms | 2 | 2018 | 1830 | 0.080 |
Why?
|
Infant | 1 | 2015 | 3045 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2019 | 8477 | 0.080 |
Why?
|
Child, Preschool | 1 | 2015 | 3611 | 0.080 |
Why?
|
Activins | 1 | 2007 | 26 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 1565 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 126 | 0.080 |
Why?
|
Vision, Ocular | 1 | 2007 | 71 | 0.080 |
Why?
|
United States | 3 | 2015 | 6665 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 2 | 2008 | 462 | 0.080 |
Why?
|
Hospital Administration | 1 | 2007 | 26 | 0.080 |
Why?
|
Axons | 1 | 2007 | 174 | 0.070 |
Why?
|
Treatment Outcome | 2 | 2020 | 7990 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 295 | 0.070 |
Why?
|
Liver Failure, Acute | 1 | 2006 | 38 | 0.070 |
Why?
|
Kidney | 1 | 2012 | 1241 | 0.070 |
Why?
|
Conscious Sedation | 2 | 1997 | 64 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 378 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2008 | 301 | 0.070 |
Why?
|
Heart Failure | 1 | 2015 | 1204 | 0.070 |
Why?
|
Brain | 2 | 2007 | 2216 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2008 | 418 | 0.060 |
Why?
|
Child | 1 | 2015 | 6926 | 0.060 |
Why?
|
Insulin | 1 | 2009 | 1160 | 0.060 |
Why?
|
Gastrointestinal Transit | 2 | 2000 | 19 | 0.060 |
Why?
|
Interleukin-8 | 2 | 2000 | 86 | 0.060 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2000 | 121 | 0.060 |
Why?
|
Equipment Design | 2 | 2018 | 406 | 0.060 |
Why?
|
Young Adult | 1 | 2015 | 5974 | 0.060 |
Why?
|
Prostatectomy | 1 | 2006 | 471 | 0.060 |
Why?
|
Receptors, Steroid | 1 | 2003 | 42 | 0.060 |
Why?
|
Morphine | 2 | 2000 | 130 | 0.050 |
Why?
|
Internship and Residency | 1 | 2011 | 1004 | 0.050 |
Why?
|
Adolescent | 1 | 2015 | 8979 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2009 | 849 | 0.050 |
Why?
|
Neural Pathways | 1 | 2003 | 308 | 0.050 |
Why?
|
Triglycerides | 1 | 2001 | 232 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2003 | 187 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2000 | 15 | 0.050 |
Why?
|
Costs and Cost Analysis | 1 | 2001 | 153 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2000 | 220 | 0.050 |
Why?
|
Macrophages, Alveolar | 1 | 2000 | 55 | 0.050 |
Why?
|
Methadone | 1 | 2000 | 36 | 0.040 |
Why?
|
Drug Interactions | 2 | 2017 | 248 | 0.040 |
Why?
|
Lipocalin-2 | 2 | 2010 | 38 | 0.040 |
Why?
|
Lipocalins | 2 | 2010 | 35 | 0.040 |
Why?
|
Acute-Phase Proteins | 2 | 2010 | 37 | 0.040 |
Why?
|
Wakefulness | 2 | 1997 | 134 | 0.040 |
Why?
|
Knowledge Bases | 1 | 2019 | 14 | 0.040 |
Why?
|
Expert Systems | 1 | 2019 | 18 | 0.040 |
Why?
|
Constipation | 1 | 2000 | 63 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2000 | 196 | 0.040 |
Why?
|
Cartilage Oligomeric Matrix Protein | 1 | 2018 | 2 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 1999 | 41 | 0.040 |
Why?
|
Pain | 1 | 2001 | 391 | 0.040 |
Why?
|
Analgesics, Opioid | 2 | 2000 | 413 | 0.040 |
Why?
|
Neutrophils | 1 | 2000 | 307 | 0.040 |
Why?
|
Athletes | 1 | 2018 | 46 | 0.040 |
Why?
|
Hip Joint | 1 | 2018 | 55 | 0.040 |
Why?
|
Sleep Hygiene | 1 | 2018 | 3 | 0.040 |
Why?
|
Physical Examination | 1 | 1999 | 149 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2014 | 2705 | 0.040 |
Why?
|
Cholinergic Agonists | 1 | 2017 | 9 | 0.040 |
Why?
|
Animals | 6 | 2022 | 26582 | 0.040 |
Why?
|
Carbachol | 1 | 2017 | 34 | 0.040 |
Why?
|
Peripheral Nervous System | 1 | 2017 | 21 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2019 | 217 | 0.040 |
Why?
|
Discrimination Learning | 1 | 2018 | 63 | 0.040 |
Why?
|
Drug Hypersensitivity | 1 | 2017 | 37 | 0.040 |
Why?
|
Cellular Microenvironment | 1 | 2017 | 27 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 1996 | 239 | 0.040 |
Why?
|
Music | 1 | 2018 | 34 | 0.040 |
Why?
|
Proteins | 1 | 2003 | 777 | 0.040 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2016 | 4 | 0.040 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2016 | 12 | 0.040 |
Why?
|
Auditory Perception | 1 | 2018 | 96 | 0.040 |
Why?
|
Neurologic Examination | 1 | 1997 | 118 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2003 | 1458 | 0.040 |
Why?
|
Cytokines | 1 | 2000 | 776 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2016 | 112 | 0.030 |
Why?
|
Smad2 Protein | 2 | 2007 | 17 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2010 | 645 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2011 | 153 | 0.030 |
Why?
|
Forecasting | 1 | 2016 | 304 | 0.030 |
Why?
|
Endotoxins | 1 | 1995 | 36 | 0.030 |
Why?
|
Quaternary Ammonium Compounds | 3 | 2000 | 79 | 0.030 |
Why?
|
Cell Survival | 1 | 2017 | 969 | 0.030 |
Why?
|
American Heart Association | 1 | 2015 | 92 | 0.030 |
Why?
|
Hypoxia | 2 | 2016 | 641 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2015 | 102 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2015 | 162 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2008 | 1753 | 0.030 |
Why?
|
Nitric Oxide | 1 | 1995 | 278 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 346 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 636 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2001 | 1823 | 0.030 |
Why?
|
Thrombelastography | 1 | 1992 | 47 | 0.030 |
Why?
|
Escherichia coli | 1 | 1995 | 597 | 0.030 |
Why?
|
Physician Assistants | 1 | 2011 | 19 | 0.030 |
Why?
|
Nurse Practitioners | 1 | 2011 | 32 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 1992 | 112 | 0.030 |
Why?
|
Hepatitis A Virus Cellular Receptor 1 | 1 | 2010 | 19 | 0.020 |
Why?
|
Lymphocytosis | 1 | 2010 | 10 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2010 | 74 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 1991 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2010 | 111 | 0.020 |
Why?
|
Masks | 1 | 2010 | 29 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 1034 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2010 | 84 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 131 | 0.020 |
Why?
|
Semiconductors | 1 | 2009 | 11 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 169 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 334 | 0.020 |
Why?
|
Israel | 1 | 2009 | 55 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2010 | 188 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1995 | 797 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 399 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 90 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2001 | 244 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2000 | 256 | 0.020 |
Why?
|
Telemedicine | 1 | 2011 | 169 | 0.020 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2008 | 21 | 0.020 |
Why?
|
Disulfides | 1 | 2008 | 64 | 0.020 |
Why?
|
Growth Cones | 1 | 2007 | 4 | 0.020 |
Why?
|
alpha Karyopherins | 1 | 2007 | 10 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 428 | 0.020 |
Why?
|
ROC Curve | 1 | 2010 | 752 | 0.020 |
Why?
|
Photoreceptor Cells, Invertebrate | 1 | 2007 | 21 | 0.020 |
Why?
|
Seizures | 1 | 2010 | 297 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2007 | 31 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2010 | 379 | 0.020 |
Why?
|
Presynaptic Terminals | 1 | 2007 | 40 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2007 | 307 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2008 | 193 | 0.020 |
Why?
|
Elective Surgical Procedures | 1 | 2008 | 116 | 0.020 |
Why?
|
Physicians | 1 | 2015 | 673 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2009 | 429 | 0.020 |
Why?
|
Supine Position | 1 | 2006 | 30 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 193 | 0.020 |
Why?
|
Mutation | 2 | 2008 | 3967 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2000 | 683 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 736 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2006 | 293 | 0.020 |
Why?
|
Kinetics | 1 | 2008 | 1513 | 0.020 |
Why?
|
Computational Biology | 1 | 2008 | 528 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2010 | 1801 | 0.020 |
Why?
|
Alleles | 1 | 2008 | 1128 | 0.020 |
Why?
|
Ischemia | 1 | 2006 | 243 | 0.020 |
Why?
|
Protein Binding | 1 | 2008 | 1456 | 0.020 |
Why?
|
Cell Movement | 1 | 2007 | 758 | 0.020 |
Why?
|
Quality of Life | 1 | 2011 | 1583 | 0.010 |
Why?
|
Mushroom Bodies | 1 | 2003 | 3 | 0.010 |
Why?
|
Activin Receptors, Type II | 1 | 2003 | 9 | 0.010 |
Why?
|
Activin Receptors, Type I | 1 | 2003 | 12 | 0.010 |
Why?
|
Genes, Lethal | 1 | 2003 | 53 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 3675 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 2818 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 270 | 0.010 |
Why?
|
Emulsions | 1 | 2001 | 19 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 286 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2003 | 276 | 0.010 |
Why?
|
Liver | 1 | 2006 | 1230 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 1749 | 0.010 |
Why?
|
Tablets, Enteric-Coated | 1 | 2000 | 6 | 0.010 |
Why?
|
Breath Tests | 1 | 2000 | 55 | 0.010 |
Why?
|
Lactulose | 1 | 2000 | 19 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 429 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2000 | 48 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 307 | 0.010 |
Why?
|
Auscultation | 1 | 1999 | 4 | 0.010 |
Why?
|
Palpation | 1 | 1999 | 18 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1999 | 274 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 684 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 916 | 0.010 |
Why?
|
Gastrointestinal Agents | 1 | 2000 | 161 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1999 | 251 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 879 | 0.010 |
Why?
|
Pilot Projects | 1 | 2000 | 839 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1997 | 63 | 0.010 |
Why?
|
Actins | 1 | 2000 | 451 | 0.010 |
Why?
|
Length of Stay | 1 | 2000 | 700 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 1208 | 0.010 |
Why?
|
APACHE | 1 | 1996 | 21 | 0.010 |
Why?
|
Patients' Rooms | 1 | 1996 | 14 | 0.010 |
Why?
|
RNA | 1 | 2000 | 560 | 0.010 |
Why?
|
Gene Expression | 1 | 2000 | 1284 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1996 | 429 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1995 | 45 | 0.010 |
Why?
|
Femoral Artery | 1 | 1995 | 81 | 0.010 |
Why?
|
Vasodilation | 1 | 1995 | 96 | 0.010 |
Why?
|
Acetylcholine | 1 | 1995 | 176 | 0.010 |
Why?
|
Arginine | 1 | 1995 | 136 | 0.010 |
Why?
|
Observer Variation | 1 | 1996 | 602 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 1546 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1999 | 1673 | 0.010 |
Why?
|
Dogs | 1 | 1995 | 685 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1995 | 989 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1996 | 492 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1995 | 912 | 0.010 |
Why?
|
Hematocrit | 1 | 1992 | 68 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1992 | 63 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1992 | 35 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1992 | 93 | 0.010 |
Why?
|
Intestines | 1 | 1995 | 411 | 0.010 |
Why?
|
Hemodynamics | 1 | 1995 | 710 | 0.010 |
Why?
|
Drainage | 1 | 1992 | 157 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1995 | 1961 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1992 | 228 | 0.010 |
Why?
|